Borregaard Declares NOK 4.75 Dividend as Shares Turn Ex-Dividend

Borregaard Returns Capital to Shareholders Following AGM Approval

Borregaard ASA ($BRRG), the Norwegian specialty chemicals and biochemicals manufacturer, commenced ex-dividend trading on 17 April 2026 following shareholder approval of a NOK 4.75 per share dividend at its Annual General Meeting held on 16 April 2026. The dividend distribution represents a tangible return of capital to investors and signals management confidence in the company's cash generation capabilities and financial position.

At the AGM, all proposed agenda items were adopted by shareholders, providing the company with a clear mandate to execute its strategic initiatives and capital allocation plans. The dividend declaration underscores Borregaard's commitment to balancing growth investments with shareholder returns—a critical consideration for income-focused investors in the specialty chemicals sector.

Dividend Details and Capital Allocation Strategy

The NOK 4.75 per share dividend represents the company's distribution to equity holders, with the ex-dividend date marking the transition point where new purchasers of shares would not be entitled to receive this specific payment. This structure is standard market practice, allowing the company to establish a precise record date for determining dividend eligibility.

Key metrics of the dividend announcement include:

• Dividend per share: NOK 4.75
• Ex-dividend date: 17 April 2026
• AGM approval date: 16 April 2026
• Shareholder vote: All agenda items adopted unanimously

The timing of the dividend—declared following the annual shareholder meeting—suggests the board's assessment of full-year financial performance and available distributable earnings. For Borregaard, maintaining a consistent dividend policy has historically been important for attracting institutional investors and maintaining valuation support, particularly in the specialty chemicals sector where cash flow stability is prized.

Market Context: Specialty Chemicals Sector Dynamics

Borregaard operates within the specialty chemicals and biochemicals industry, a sector characterized by diverse end-market exposure, including pharmaceuticals, personal care, food production, and industrial applications. The company's ability to declare and maintain dividends reflects both its operational performance and the sector's underlying health.

Specialty chemical companies typically face:

• Commodity price exposure: Raw material cost volatility affecting margins
• End-market cyclicality: Demand correlation with manufacturing and consumer spending
• Regulatory compliance: Environmental and safety standards requiring ongoing capital investment
• Competitive intensity: Competition from larger diversified chemical companies and regional players

In this context, Borregaard's dividend declaration signals management's confidence that the company can simultaneously:

1. Fund necessary capital expenditures for capacity expansion and modernization
2. Invest in research and development for product innovation
3. Maintain financial flexibility for strategic acquisitions or debt reduction
4. Return excess capital to shareholders

The specialty chemicals sector has faced mixed headwinds in recent years, with input cost pressures and economic uncertainty requiring disciplined capital allocation. Borregaard's ability to declare a meaningful dividend while navigating these challenges positions it favorably relative to peers facing margin compression.

Investor Implications and Valuation Considerations

For equity investors in Borregaard ($BRRG), the dividend has several strategic implications:

Income Generation: The NOK 4.75 per share dividend provides an immediate income component to total returns, appealing to dividend-focused investors and those seeking portfolio yield in a low-rate environment.

Capital Discipline: The shareholder approval of all AGM items without noted dissent suggests investor confidence in management's strategic direction and capital allocation framework. This consensus strengthens the board's mandate for executing planned initiatives.

Financial Health Signal: Companies that maintain or grow dividends during uncertain periods typically demonstrate stronger underlying cash flow generation and balance sheet resilience than those cutting distributions. The dividend maintenance reflects Borregaard's financial stability.

Valuation Dynamics: The ex-dividend date (17 April 2026) typically results in share price adjustment as the dividend value accrues to shareholders of record. Investors should anticipate standard ex-dividend technical adjustments, though longer-term valuation will depend on earnings growth and market sentiment toward specialty chemicals exposure.

Forward-Looking Considerations

The dividend declaration establishes a baseline expectation for shareholder returns, though future distributions will depend on Borregaard's financial performance, capital requirements, and board discretion. Investors should monitor:

• Quarterly earnings reports for cash flow trends and working capital management
• Capital expenditure plans for major facility investments or capacity expansion
• Sector dynamics affecting demand for specialty biochemicals and industrial chemicals
• Sustainability initiatives and regulatory compliance costs that may impact capital allocation

The unanimous adoption of AGM agenda items provides Borregaard with operational flexibility and shareholder support as the company navigates an evolving chemical industry landscape. For income-oriented investors, the declared dividend represents a meaningful return, while growth-focused shareholders should monitor whether retained earnings successfully drive competitive advantages and market share gains.

Borregaard's dividend declaration reflects a maturing company confident in its market position and cash generation capability, offering both current income and exposure to the specialty chemicals sector's long-term growth drivers.